Method for improving the yield of immunoantibodies in the vaccin

Details Method for improving the yield of immunoantibodies in the vaccin Method for improving the yield of immunoantibodies in the vaccin

1997-03-19

1999-07-06

Minnifield, Nita

Drug, bio-affecting and body treating compositions

Nonspecific immunoeffector, per se ; or nonspecific...

4241841, 424450, 5303881, 5303891, A61K 4500, A61K 3900, A61K 4700, C07K 1600

Patent

active

059194669

ABSTRACT:
Immunological adjuvant containing GMDP (N-acetyl-glucos-aminyl-N-acetylmuramyl-L-alanyl-D-isoglutamine) and a colloidal, ultrafiltrable solution of solid, biodegradable lipids suitable as an additive in veterinary and human vaccines.

REFERENCES:
patent: 4036953 (1977-07-01), Adam et al.
patent: 4082735 (1978-04-01), Jones et al.
patent: 4094971 (1978-06-01), Chedid et al.
patent: 4395399 (1983-07-01), Ovchinnikov et al.
patent: 4774085 (1988-09-01), Fidler
patent: 4845042 (1989-07-01), Newman et al.
patent: 4877777 (1989-10-01), DiLuzio
patent: 4880634 (1989-11-01), Speiser
patent: 5032401 (1991-07-01), Jamas et al.
patent: 5049390 (1991-09-01), Wojdani
patent: 5100591 (1992-03-01), LeClef et al.
patent: 5210072 (1993-05-01), Chedid et al.
patent: 5340588 (1994-08-01), Domb
patent: 5376369 (1994-12-01), Allison et al.
patent: 5409698 (1995-04-01), Anderson et al.
patent: 5538733 (1996-07-01), Emery et al.
patent: 5607677 (1997-03-01), Jamas et al.
patent: 5612042 (1997-03-01), Jacobs
patent: 5622649 (1997-04-01), Hunter et al.
patent: 5650152 (1997-07-01), Anderson et al.
patent: 5665382 (1997-09-01), Grinstaff et al.
patent: 5665383 (1997-09-01), Grinstaff et al.
patent: 5679355 (1997-10-01), Alexander et al.
patent: 5773011 (1998-06-01), Grubhofer
Clough et al Inf. & Imm. 48/3:839-42, 1985.
Parant et al, Infectiion 13 (Suppl 2):S251-S255, 1985.
Riveau et al; J. Leukocyte Biology 44:448-54, 1988.
Solange, Chemistry & Physics of Lipids, 75:51-58, 1995.
Gregoriadis et al, Immunol Letters, 20:237-40, 1989.
Shimizu et al, Int. J. Immunopharmac. 14(8):1415-1420, 1992.
Yin et al, J. Biological Response Modifiers 8: 190-205, 1989.
Alam et al, Immunol Letters, 27: 53-58, 1991.
Allison et al, Tech. Adv. Vac. Development pp. 401-409, 1988.
Nesmeyanov et al, Biomed. Sci., 1(2):151-54, 1990.
Domkus et al. 5th Int'l Congress on Anti-Cancer Chemotherapy Poster #P517, 1995.
Byars et al, Vaccine 5:223-228, 1987.
Hilgers et al, Res. Immunol, 143: 494-503, 1992.
Mozes et al, PNAS, USA, 77(8): 4933-4937, Aug. 1980.
Shapira et al, Int. J. Immunopharmac. 7(5):719-723, 1985.
Ramasaney et al, J. Natl. Sci. Council, Sri Lanka, 21(1):125-140, 1993.
Amar et al, Mol. Immunol., 24(9):945-951, 1987.
Sharma et al Tech. Adv. Vaccine Development pp. 107-116 Alan R Liss Inc., 1988.
Grubhofer et al, FASEB Journal 8(4-5):A993, 1994.
Arakawa, Adv. Drug Del. Reviews, 10:1-28, 1993.
Grubhofer, Immunol Letters, 44:19-24, 1995.
Andronova et al, Colloq. INSERM 174(Forum Pept. 2nd, 1988):561-564, 1989.
Carelli et al Infection & Imm. 33(1):312-314, Jul. 1981.
Hilgers et al, Cellular Immunol, 90:14-23, 1985.
Hilgers et al, Cellular Immunol, 86:393-401, 1984.
Hilgers et al, Cellular Immunol. 92:203-209, 1985.
Hilgers et al, Int. Archs. All. Appl. Immunol 79:388-391, 1986.
Hilgers et al Int. Archs. All. Appl. Immunol 79:392-396, 1986.
Edelman et al, Intern. Rev. Immunol 7:51-66, 1990.
"A New Generation Of Softeners" published in the Journal for Theory, Technology and Application of Surfactants by Carl Hanser Verlag, Munchen, Germany (Jan. 1993).
"Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines (MF59)" published in Vaccine Design: The Subunit and Adjuvant Approach, Chapter 10, by Gary Ott, Gail L. Barchfeld, David Chernoff, Ramachandran Radhakrishnan, Peter van Hoogevest and Gary Van Nest. (1995).
"A Comparison of Commercially Available Adjuvants for Use in Research" published in the Journal of Immunological Methods, by Beth Bennett, Irene J. Check, Margarent R. Olsen and Robert L. Hunter (1992).
"The Control of the Antibody Isotype Response to Recombinat Human Immunodeficiency Virus gp120 Antigen by Adjuvants" published in Aids Research and Human.sub.-- viruses, vol. 8, No. 10, by R. Bomford, M. Stapleton, S.Winsor, A McKnight and T. Andronova (1992).
"Minimal Structural Requirements for Adjuvant Activity of Bacterial Peptidoglycan Derivatives" published in Biochemical and Biophysical Research Communications, vol. 59, No. 4, by Farielle Ellouz, Arlette Adam, Rita Ciorbaru and E. Lederer (1974).
"Antibody Formation and Sensitization with the Aid of Adjuvants" by Jules Freund, K. Jefferson Thomson, H.B. Hough, H.E. Sommer and T.M. Pisani (1948).
"The Mode of Action of Immunologic Adjuvants" by Jules Freund.
"Future Prospects for Vaccine Adjuvants" published in CRC Critical Reviews in Immunology, vol. 8, Issue 2, by H. Shaw Warren and Louis A. Chedid. (1988).
"The Adjuvant Activity of Nonionic Block Polymer Surfactants" published in the Journal of Immunology, vol. 133, No. 6, Dec. 1984, by Robert L. Hunter and Beth Bennett.
"An Adjuvant Formation That Selectively Elicits the Formation of Antibodies of Protective Isotypes and of Cell-mediated Immunity" published in the Journal of Immunological Methods, by Anthony C. Allison and Noelene E. Byars (1986).
"The Structure and Immunomodulating Function of Gluosaminylmuramyl Peptides" published in Sov. Medical Review D. Immunology, vol. 4, pp. 1-63, by Tatyana Andronova and Vadim Ivanov (1991).
Immunoadjuvant Activities of Synthetic N-Acetyl-Muramyl-Peptides or Amino Acids, published in Biken Journal, vol. 18, pp. 105-111, by Shozo Kotani, Yoshiro Watanabe, Fumio Kinoshita, Tsutomu Shimono, Ichijiro Morisaki, Tetsuo Shiba, Shoichi Kusumoto, Yuzo Tarumi and Kazuhiro Ikenaka (1975).
"Adjuvant Activity of 6-0-Acyl-Muramyldipeptides to Enhance Primary Cellular and Humoral Immune Responses to Guinea Pigs: Adaptability to Various Vehicles and Progenicity", published in Infection and Immunity, by Masachika Tsujimoto, Shozo Kotani, Fumio Kinoshita, Seizaburo Kanoh, Tetseuo Shiba and Shoichi Kusumoto (1986), 53(3):511-516.
"Adjuvant Formulation for use in Vaccines to Elicit both Cell-mediated and Humoral Immunity" published in Vaccine, vol. 5, by Noelene E. Byars and Anthony C. Allison (1987).
"A Compendium of Vaccine Adjuvants and Excipients" published in Vaccine Design, by Frederick R. Vogel and Michael F. Powell (1994).
"Adjuvants for Viral Vaccines" published in Reviews in Medical Virology, vol. 2, pp. 169-174, by R. Bomford (1992).

Affiliated with

Also associated with

Rating

Method for improving the yield of immunoantibodies in the vaccin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for improving the yield of immunoantibodies in the vaccin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for improving the yield of immunoantibodies in the vaccin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-897348